Medifast, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St futures slip as oil surge puts markets on edge
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Medifast (MED) Tops Q4 EPS by 59c, Revenues Beat; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus
February 26, 2020 4:46 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $1.66, $0.59 better than the analyst estimate of $1.07. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $161.69 million.
Fourth Quarter 2019 Highlights Compared to Prior-Year Period
Revenue up 17.0% to $170.6 million32.0% growth in active earning OPTAVIA Coaches to 31,800Net income increased 27.0% to $19.9 millionEarnings per diluted share ("EPS") of $1.66, an increase of 27.7%Declared a quarterly cash dividend of $13.4 million, or $1.13 per share paid on February 6, 2020, an increase of over 50%... More